Molly Harper Catalyst Pharmaceuticals, Inc. (CPRX) insider trading activity

Molly Harper is Director of CATALYST PHARMACEUTICALS, INC.. Currently has a direct ownership of 3,694 shares of CPRX, which is worth approximately $85,626. The most recent transaction as insider was on Dec 29, 2025, when has been sold 1,334 shares (Common Stock, par value $0.001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.69K

45.24% 3M change

34.52% 12M change

Total Value Held $85,626

Molly Harper Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 29 2025	BUY Exercise of conversion of derivative security	-	1,334 Added 26.53%	3,694 Common Stock, par valu...
Dec 12 2025	SELL Open market or private sale	$623,984 $23.33 p/Share	26,746 Reduced 91.89%	2,360 Common Stock, par valu...
Dec 12 2025	BUY Exercise of conversion of derivative security	$115,600 $5.78 p/Share	20,000 Added 40.73%	29,106 Common Stock, par valu...
Dec 08 2025	BUY Exercise of conversion of derivative security	-	1,413 Added 13.43%	9,106 Common Stock, par valu...
Nov 21 2025	BUY Exercise of conversion of derivative security	-	947 Added 10.96%	7,693 Common Stock, par valu...
Feb 14 2025	BUY Exercise of conversion of derivative security	-	4,000 Added 37.22%	6,746 Common Stock, par valu...
Dec 27 2024	BUY Exercise of conversion of derivative security	-	1,333 Added 32.68%	2,746 Common Stock, par valu...

Dec 09 2024	BUY Exercise of conversion of derivative security	-	1,413 Added 50.0%	1,413 Common Stock, par valu...
Nov 27 2024	SELL Open market or private sale	$385,000 $22.0 p/Share	17,500 Reduced 100.0%	0 Common Stock, par valu...
Nov 27 2024	BUY Exercise of conversion of derivative security	$101,150 $5.78 p/Share	17,500 Added 50.0%	17,500 Common Stock, par valu...
Jun 03 2024	SELL Open market or private sale	$86,927 $16.3 p/Share	5,333 Reduced 100.0%	0 Common Stock, par valu...
Feb 15 2024	BUY Exercise of conversion of derivative security	-	4,000 Added 42.86%	5,333 Common Stock, par valu...
Dec 27 2023	BUY Exercise of conversion of derivative security	-	1,333 Added 50.0%	1,333 Common Stock, par valu...
Dec 15 2023	SELL Open market or private sale	$201,600 $14.4 p/Share	14,000 Reduced 100.0%	0 Common Stock, par valu...
Dec 15 2023	BUY Exercise of conversion of derivative security	$57,800 $5.78 p/Share	10,000 Added 50.0%	10,000 Common Stock, par valu...
Feb 15 2023	BUY Exercise of conversion of derivative security	-	4,000 Added 50.0%	4,000 Common Stock, par valu...

Molly Harper

Director

Coral Gables, FL

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CPRX shares.

Notify only if

Value

Insider Trading

Get notified when an Catalyst Pharmaceuticals, Inc. insider buys or sells CPRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to CATALYST PHARMACEUTICALS, INC.

Track Activities on CPRX

Account